Recurrent diffuse large B-cell lymphoma activated B-cell type

Clinical trials for Recurrent diffuse large B-cell lymphoma activated B-cell type explained in plain language.

Never miss a new study

Get alerted when new Recurrent diffuse large B-cell lymphoma activated B-cell type trials appear

Sign up with your email to follow new studies for Recurrent diffuse large B-cell lymphoma activated B-cell type, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New drug combo may boost stem cell transplant success in hard-to-treat lymphoma

Disease control Ongoing

This study tests whether adding the drug ibrutinib to standard chemotherapy before and after a stem cell transplant helps people with a specific type of lymphoma (activated B-cell diffuse large B-cell lymphoma) that has returned or not responded to treatment. About 94 participant…

Matched conditions: RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA ACTIVATED B-CELL TYPE

Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

Recurrent diffuse large B-cell lymphoma activated B-cell type

Get alerted when new Recurrent diffuse large B-cell lymphoma activated B-cell type trials appear

New drug combo may boost stem cell transplant success in hard-to-treat lymphoma